Block and Erector Comparative Study Between Costotransverse Spinae Plane Block in Patients Undergoing Thoracotomy

Sohag University

Status: Not yet enrolling

Conditions: Pain Mangement of Thoracotomy

Treatments: Drug: Bupivacaine 0.25% Injectable Solution

Study type: Interventional

Funder types: Other

Identifiers

NCT06301334

Soh-Med-24-01-11MS

Details and patient eligibility

About

A thoracotomy requires a very painful incision, involving multiple muscle layers, rib resection and continuous motion as the patient breathes. Treatment of acute post thoracotomy pain is particularly important not only to keep the patient comfortable but also to minimize pulmonary complications

Though epidural analgesia was once considered as the gold standard for post-thoracotomy pain management, it is not recommended for pain control after thoracotomy surgery because it is associated with high potential risks of dural puncture, nerve lesions, epidural hematoma and hypotension(4). Thoracic paravertebral block (TPVB) and intercostal nerve block are well described and recognized techniques for postoperative analgesia following thoracic surgeries, such as thoracotomy and mastectomy

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • Age from 18 to 75 years old.

  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I-II-III.
  • Patient undergoing unilateral thoracotomy surgery.

Exclusion criteria

• • BMI more than 30 kg/m2.

  • Patients who are taking analgesics for chronic illness or have a history of substance abuse.
  • Patients who are unable to describe their postoperative pain (e.g., language barrier or neuropsychiatric disorder).
  • Patients with a history of coagulopathy.
  • Severe heart diseases.
  • Hepatic or renal insufficiency.
  • Infection at the site of infiltration

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Group CTB

Active Comparator group

Description:

n=30): patients included in this group will receive unilateral US-guided CTB after general anesthesia. The CTB will be performed by using 20 ml bupivacaine 0.25%

Treatment:

Drug: Bupivacaine 0.25% Injectable Solution

Group ESPB

Active Comparator group

Description:

patients included in this group will receive unilateral US-guided ESPB after general anesthesia. The ESB will be performed by using 20 ml bupivacaine 0.25%

Treatment:

Drug: Bupivacaine 0.25% Injectable Solution